You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade

Article metrics

Article menu

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade

 

Online download statistics by month:

Online download statistics by month: June 2020 to September 2024

AbstractFullPdf
Jun 202027627785
Jul 202018718754
Aug 202011711528
Sep 2020808118
Oct 2020454525
Nov 2020525226
Dec 2020414121
Jan 2021909027
Feb 2021868619
Mar 202118218217
Apr 2021616120
May 2021343412
Jun 202143438
Jul 2021484816
Aug 202111211227
Sep 2021727220
Oct 2021474740
Nov 2021464629
Dec 2021474719
Jan 2022282910
Feb 2022283414
Mar 2022485130
Apr 2022373919
May 2022606232
Jun 2022454513
Jul 2022394017
Aug 2022323249
Sep 2022303116
Oct 2022373714
Nov 2022343627
Dec 202219197
Jan 2023181810
Feb 2023535311
Mar 202327288
Apr 2023141423
May 2023272725
Jun 2023222212
Jul 2023313115
Aug 202318188
Sep 2023262811
Oct 202331319
Nov 202323239
Dec 202327279
Jan 2024202110
Feb 2024303018
Mar 2024262646
Apr 2024323225
May 2024242513
Jun 2024414125
Jul 2024363719
Aug 2024242512
Sep 2024222215
Total267527001092